Live Breaking News & Updates on Lina Yao

Stay updated with breaking news from Lina yao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Teon Therapeutics Completes $30 Million Series A Financing


Teon Therapeutics Completes $30 Million Series A Financing
News provided by
Share this article
Share this article
SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/  Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, today announced the completion of a $30M Series A financing. The financing was led by Oceanpine Capital with participation from additional new investors Oriza Ventures, Lifespan Investments, and former Gilead senior executives. All existing investors also participated in the financing round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital. The funds will be used to advance the company s lead A ....

Hong Kong , United Kingdom , Feng Deng , Lina Yao , Dave Chenn , Teon Therapeutics Inc , Cancer Research United Kingdom , Teon Therapeutics , Oceanpine Capital , Oriza Ventures , Lifespan Investments , Northern Light Venture Capital , Kaitai Capital , Oriental Fortune , Chief Executive Officer , Managing Partner , Founding Managing Partner , Northern Light Venture , Silicon Valley , ஹாங் காங் , ஒன்றுபட்டது கிஂக்டம் , ஃபெங் டெங் , லினா யாவ் , புற்றுநோய் ஆராய்ச்சி ஒன்றுபட்டது கிஂக்டம் , ஆயுட்காலம் முதலீடுகள் , வடக்கு ஒளி துணிகர மூலதனம் ,

Teon Therapeutics Appoints Glen Giovannetti as Independent Board Member


Teon Therapeutics Appoints Glen Giovannetti as Independent Board Member
News provided by
Share this article
Share this article
SAN FRANCISCO, Jan. 12, 2021 /PRNewswire/ Teon Therapeutics, a private biopharmaceutical company developing a focused portfolio of small molecules that modulate metabolic signaling pathways in the tumor microenvironment, today announced the appointment of Glen Giovannetti, to its board of directors. Glen brings over 36 years of leadership success, industry expertise and board governance credentials following his retirement from EY (Ernst & Young) in December 2020. As EY s former Global Biotechnology and Life Sciences Leader, Glen has deep life sciences knowledge and financial governance, risk and reporting expertise. We are excited to have Glen joining our board, said Ken Horne, President and Chief Operating Officer of Teon Therapeutics. His experience as lead partner on numerous IPOs and M&A transactions in the biotech industry will ....

Glen Giovannetti , Feng Deng , Ken Horne , Lou Lange , Ernst Young , Lina Yao , Life Sciences Leader , Teon Therapeutics Inc , Global Biotechnology , Chief Operating Officer , Founding Managing Director , Northern Light Ventures , Teon Therapeutics , ஃபெங் டெங் , கேன் கொம்பு , லூ லாங்கே , எர்னிஸ்ட இளம் , லினா யாவ் , வாழ்க்கை அறிவியல் தலைவர் , உலகளாவிய உயிரி தொழில்நுட்பவியல் , தலைமை இயங்குகிறது அதிகாரி , ஸ்தாபகம் நிர்வகித்தல் இயக்குனர் , வடக்கு ஒளி முயற்சிகள் ,